Pharmacology, Toxicology and Pharmaceutical Science
Mycobacterium Tuberculosis
67%
Infection
22%
Mouse
18%
Isoniazid
18%
Disease
16%
Tuberculosis
14%
Moxifloxacin
13%
Mouse Model
12%
HIV
9%
Drug Resistance
8%
Rifampicin
8%
Tuberculostatic Agent
8%
Diphtheria Toxin
7%
Infectious Agent
7%
Antiinfective Agent
7%
Pyrazinamide
7%
Bacilli
7%
Quinolone Derivative
7%
Streptococcus Pneumoniae
6%
Pharmacokinetics
6%
Latent Tuberculosis
6%
Mycolic Acid
5%
Carboxamide
5%
Rifapentine
5%
Interferon
5%
Lactam
5%
Antibiotics
5%
Ethambutol
5%
Extensively Drug-Resistant Tuberculosis
5%
Indole
5%
Granuloma
5%
Immunology and Microbiology
Mycobacterium Tuberculosis
100%
Mouse
31%
Macrophage
13%
Promoter Region
12%
Sigma Factor
12%
Wild Type
12%
Mycobacterium Bovis BCG
11%
Infectious Agent
10%
Granuloma
10%
Bacilli
9%
Immune Response
9%
Mycobacteria
8%
Escherichia coli
8%
Gene Expression
7%
Human Immunodeficiency Virus
7%
Bactericidal Activity
6%
Mouse Model
6%
Guinea Pig
5%
Vaccine Efficacy
5%
Regulatory T Cell
5%
Drug Resistance
5%
BCG Vaccine
5%
T Cell
5%
Keyphrases
Mycobacterium Tuberculosis (M. tb)
50%
Tuberculosis
47%
Tuberculosis Treatment
12%
Mouse Model
9%
Moxifloxacin
9%
Lung
8%
Host-directed Therapy
7%
Drug Resistance
6%
Murine Model
5%
Myeloid-derived Suppressor Cells
5%
Pyrazinamide
5%
Active Tuberculosis
5%